Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis
Preneoplastic and neoplastic hepatocytes undergo c-Myc up-regulation and overgrowth in rats genetically susceptible to hepatocarcinogenesis, but not in resistant rats. Because c-Myc regulates the pRb-E2F pathway, we evaluated cell cycle gene expression in neoplastic nodules and hepatocellular carcin...
Saved in:
Published in | Hepatology (Baltimore, Md.) Vol. 35; no. 6; pp. 1341 - 1350 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Elsevier Inc
01.06.2002
W.B. Saunders Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Preneoplastic and neoplastic hepatocytes undergo c-Myc up-regulation and overgrowth in rats genetically susceptible to hepatocarcinogenesis, but not in resistant rats. Because c-Myc regulates the pRb-E2F pathway, we evaluated cell cycle gene expression in neoplastic nodules and hepatocellular carcinomas (HCCs), induced by initiation/selection (IS) protocols 40 and 70 weeks after diethylnitrosamine treatment, in susceptible Fisher 344 (F344) rats, and resistant Wistar and Brown Norway (BN) rats. No interstrain differences in gene expression occurred in normal liver. Overexpression of c-
myc, Cyclins D1, E, and
A, and
E2F1 genes, at messenger RNA (mRNA) and protein levels, rise in Cyclin D1-CDK4, Cyclin E-CDK2, and E2F1-DP1 complexes, and pRb hyperphosphorylation occurred in nodules and HCCs of F344 rats. Expression of
Cdk4, Cdk2, p16
INK4A,
and
p27
KIP1
did not change. In nodules and/or HCCs of Wistar and BN rats, low or no increases in c-
myc, Cyclins D1, E, and
A, and
E2F1 expression, and Cyclin-CDKs complex formation were associated with
p16
INK4A
overexpression and pRb hypophosphorylation. In conclusion, these results suggest deregulation of G1 and S phases in liver lesions of susceptible rats and block of G1-S transition in lesions of resistant strains, which explains their low progression capacity. (H
EPATOLOGY 2002;35:1341-1350.) |
---|---|
ISSN: | 0270-9139 1527-3350 |
DOI: | 10.1053/jhep.2002.33682 |